SCHEMBL7601768

SCHEMBL7601768

C[C@H](CO)OC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3626522 1.00
SCHEMBL2383537 1.00
SCHEMBL29728566 0.81 TSHR (0.60)
SCHEMBL4009243 0.80
SCHEMBL28384882 0.80
SCHEMBL23725742 0.79
SCHEMBL473155 0.79
SCHEMBL3504870 0.79
SCHEMBL225530 0.79 TSHR (0.58)
SCHEMBL25200468 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110637015-A Farnesoin X receptor agonists and uses thereof 梅塔科林公司 2019-12-31 CN claimed
EP-1266900-A1 Carbamates of rapamycin Wyeth (US) 2002-12-18 EP claimed
EP-0593227-A1 Carbamates of rapamycin AMERICAN HOME PRODUCTS CORPORATION (US) 1994-04-20 EP claimed
US-5302584-A Immunosuppressants AMERICAN HOME PRODUCTS CORPORATION (US) 1994-04-12 US claimed
CN-118239948-A Solid forms and methods of making fused tricyclic compounds, including methods of use thereof 豪夫迈·罗氏有限公司 2024-06-25 CN disclosed
CN-117946107-A Solid forms and methods of making fused tricyclic compounds, including methods of use thereof 豪夫迈·罗氏有限公司 2024-04-30 CN disclosed
CN-117897146-A Novel process for synthesizing enantiomerically pure (S) -methadone, (R) -methadone, racemic (R, S) -methadone and related analogues 保罗·L·曼佛雷蒂 2024-04-16 CN disclosed
EP-4349828-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shanghai Yingli Pharmaceutical Co. Ltd. (CN) 2024-04-10 EP disclosed
US-20230391785-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, METHOD FOR PREPARING SAME AND USE OF SAME 280 BIO, INC. (US) 2023-12-07 US disclosed
CN-117120429-A KHK inhibitor 吉利德科学公司 2023-11-24 CN disclosed
CN-116724038-A Bicyclic compounds 安力高医药股份有限公司 2023-09-08 CN disclosed
CN-116514813-A Preparation method of tyrosine kinase inhibitor and intermediate thereof 轩竹生物科技股份有限公司 2023-08-01 CN disclosed
CN-101801939-A Be used to strengthen the 3-replacement 1,2 of glutamatergic synaptic responses, 3-triazine-4-ketone and 3-replace 1, the 3-Pyrimdinone CORTEX PHARMA INC 2010-08-11 CN disclosed
CN-101641093-A Imidazotriazines and imidazopyrimidines as kinase inhibitors INCYTE CORP US 2010-02-03 CN disclosed
WO-2009080676-A1 NEW CALB MUTEINS AND THEIR USE BASF SE (DE) 2009-07-02 WO disclosed
CN-101212903-A Polycyclic carbamoylpyridone derivatives having HIV integrase inhibitory activity SMITHKLINE BEECHAM CORP (US) 2008-07-02 CN disclosed
EP-1266900-A1 Carbamates of rapamycin Wyeth (US) 2002-12-18 EP disclosed
US-5411967-A Antiinflammatory, immunosuppressant, antitumor AMERICAN HOME PRODUCTS CORPORATION (US) 1995-05-02 US disclosed
EP-0593227-A1 Carbamates of rapamycin AMERICAN HOME PRODUCTS CORPORATION (US) 1994-04-20 EP disclosed
US-5302584-A Immunosuppressants AMERICAN HOME PRODUCTS CORPORATION (US) 1994-04-12 US disclosed